文献速递脑血管病

急性或延迟全身给予人羊膜上皮细胞改善实验性卒中结局

Acute or Delayed Systemic Administration of Human Amnion Epithelial Cells Improves Outcomes in Experimental Stroke.
PubMed 文献 · Stroke · 2018-01-30

该研究在四种脑缺血动物模型中测试卒中后急性(1.5小时)或延迟(1-3天)静脉注射人羊膜上皮细胞(hAECs)的疗效,包括年轻和老年雌雄小鼠及成年狨猴。结果显示hAECs可迁移至缺血脑组织、减少脑炎症和梗死并改善功能缺陷,延迟给药仍增强长期功能恢复,狨猴中急性注射可预防卒中后第1至10天的梗死发展。

要点

  • 小鼠卒中后1.5小时给予hAECs经CXCR4依赖机制迁移至缺血脑,减少炎症、梗死和功能缺陷。
  • 卒中后1或3天延迟给予hAECs仍增强年轻和老年雌雄小鼠的长期功能恢复。
  • 狨猴中急性静脉注射hAECs可预防卒中后第1至10天的梗死发展。

核心结论

  • 卒中后全身给予hAECs可产生明显神经保护作用并促进修复和恢复机制。

研究设计与样本

  • 在4种已建立的脑缺血动物模型中测试卒中后急性(1.5小时)或延迟(1-3天)静脉注射hAECs的疗效。
  • 动物包括年轻(7-14周)和老年(20-22个月)雌雄小鼠以及成年雌雄狨猴。

主要发现

  • 小鼠卒中后1.5小时给予hAECs经CXC趋化因子受体4依赖机制迁移至缺血脑,减少脑炎症、梗死发展和功能缺陷。
  • 卒中后延迟至1或3天给予hAECs,年轻和老年雌雄小鼠的长期功能恢复仍增强。
  • 狨猴中急性静脉注射hAECs可预防卒中后第1天至第10天的梗死发展。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: Human amnion epithelial cells (hAECs) are nonimmunogenic, nontumorigenic, anti-inflammatory cells normally discarded with placental tissue. We reasoned that their profile of biological features, wide availability, and the lack of ethical barriers to their use could make these cells useful as a therapy in ischemic stroke. METHODS: We tested the efficacy of acute (1.5 hours) or delayed (1-3 days) poststroke intravenous injection of hAECs in 4 established animal models of cerebral ischemia. Animals included young (7-14 weeks) and aged mice (20-22 months) of both sexes, as well as adult marmosets of either sex. RESULTS: We found that hAECs administered 1.5 hours after stroke in mice migrated to the ischemic brain via a CXC chemokine receptor type 4-dependent mechanism and reduced brain inflammation, infarct development, and functional deficits. Furthermore, if hAECs administration was delayed until 1 or 3 days poststroke, long-term functional recovery was still augmented in young and aged mice of both sexes. We also showed proof-of-principle evidence in marmosets that acute intravenous injection of hAECs prevented infarct development from day 1 to day 10 after stroke. CONCLUSIONS: Systemic poststroke administration of hAECs elicits marked neuroprotection and facilitates mechanisms of repair and recovery.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Evans MA, Lim R, Kim HA, et al. Acute or Delayed Systemic Administration of Human Amnion Epithelial Cells Improves Outcomes in Experimental Stroke. Stroke. 2018. PMID: 29382802. doi:10.1161/STROKEAHA.117.019136

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。